Iju Case Reports

SEP 25, 2026 · JOURNAL ARTICLE

Pseudoprogression During Enfortumab Vedotin Plus Pembrolizumab Therapy in Muscle‐Invasive Bladder Cancer Achieving Pathological Complete Response: A Case Report

Iju Case Reports

ABSTRACT Introduction Enfortumab vedotin plus pembrolizumab has emerged as a standard first‐line therapy for advanced urothelial carcinoma (UC). However, pseudoprogression during t

AUG 18, 2026 · JOURNAL ARTICLE

Remarkable Response to Immune Checkpoint Inhibition After Early Aggressive Recurrence Following Robot‐Assisted Radical Cystectomy for Bladder Squamous Cell Carcinoma: A Case Report

Iju Case Reports

A single case report of unexpected response to checkpoint inhibition in a rare cancer subtype raises a mechanistic question but provides no comparative evidence, control group, or generalizable data.

AUG 7, 2026 · JOURNAL ARTICLE

Urethral Metastasis of Therapy‐Induced Neuroendocrine Prostate Cancer Successfully Managed With Chemoradiotherapy: A Case Report

Iju Case Reports

A single case report of an exceptionally rare presentation (urethral metastasis of therapy-induced neuroendocrine prostate cancer) treated with chemoradiotherapy, describing outcome in one patient without comparator or control group.